Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ShefaBone vs Bio-Oss in Maxillary Sinus Grafting
NCT04433117Phase 2Completed
- Start
- Jun 2020
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Phase 2, randomised trial (2 arms). Primary endpoint: Maxillary Sinus Bone Density at 5 months. Started Jun 2020; status: completed.
Beyond the preview
Go deeper on NCT04433117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433117.